Papers: 10.1016/S2352-3018(18)30071-7

https://doi.org/10.1016/S2352-3018(18)30071-7

Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial

Cited by: 74
Author(s): Linda‐Gail Bekker, Zoe Moodie, Nicole Grunenberg, Fatima Laher, Georgia D. Tomaras, Kristen W. Cohen, Mary Allen, Mookho Malahleha, Kathryn Mngadi, Brodie Daniels, Craig Innes, Carter Bentley, Nicole Frahm, Daryl E. Morris, Lynn Morris, Nonhlanhla N. Mkhize, David C. Montefiori, Marcella Sarzotti‐Kelsoe, Shannon Grant, Chenchen Yu, Vishu Mehra, Michael Pensiero, Sanjay Phogat, Carlos A. DiazGranados, Susan W. Barnett, Niranjan Kanesa-thasan, Marguerite Koutsoukos, Nelson L. Michael, Merlin L. Robb, James G. Kublin, Peter B. Gilbert, Lawrence Corey, Glenda Gray, M. Juliana McElrath
Published: about 7 years ago

Software Mentions 1